Preferred Label : Spastic paraplegia 10, autosomal dominant;
Symbol : SPG10;
CISMeF acronym : SPG10;
Type : Phenotype, molecular basis known;
Alternative titles and symbols : Spastic paraplegia 10 with or without peripheral neuropathy;
Description : SPG10 is an autosomal dominant neurologic disorder with variable manifestations. Some
patients have onset of a 'pure' spastic paraplegia, with lower limb spasticity, hyperreflexia,
extensor plantar responses, and variable involvement of the upper limbs beginning
in childhood or young adulthood. Some patients show distal sensory impairment, which
can be part of the 'pure' phenotype. However, some patients also show an axonal sensorimotor
peripheral neuropathy with distal sensory impairment and distal muscle atrophy reminiscent
of Charcot-Marie-Tooth disease type 2 (see, e.g., CMT2A, 118210). Rarely, patients
with KIF5A mutations may have additional neurologic features, including parkinsonism
or cognitive decline, consistent with a 'complicated' phenotype. Spastic paraplegia
and peripheral neuropathy in isolation may represent extreme ends of the phenotypic
spectrum of KIF5A mutations (summary by Goizet et al., 2008 and Crimella et al., 2012).;
Inheritance : Autosomal dominant;
Molecular basis : Caused by mutation in the kinesin-5A gene (KIF5A, 602821.0001);
Prefixed ID : #604187;
Origin ID : 604187;
UMLS CUI : C1858712;
Currated CISMeF NLP mapping
DO Cross reference
Genes related to phenotype
HPO term(s)
ORDO concept(s)
Semantic type(s)
UMLS correspondences (same concept)